Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in QURE — uniQure N.V.

CIK 1423053 MIAMI, FL
Back to QURE Full portfolio

Position in QURE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,614,637
-$4,615,711 QoQ
Shares Held
404,565
-13.8% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Mar 31, 2026
CallValue
$15,630,600
CallShares
956,000
PutValue
$7,692,675
PutShares
470,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. QURE ranks #109 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in QURE

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,614,637 404,565
2026-03-31 $15,630,600 956,000
2026-03-31 $7,692,675 470,500
2025-12-31 $11,230,348 469,300
2025-12-31 $11,562,976 483,200
2025-12-31 $19,440,732 812,400
2025-09-30 $35,255,480 604,000
2025-09-30 $25,082,172 429,710
2025-09-30 $15,759,900 270,000
2025-06-30 $7,748,757 555,865
2025-06-30 $1,757,834 126,100
2025-06-30 $1,831,716 131,400
2025-03-31 $8,324,391 785,320
2025-03-31 $1,323,940 124,900
2025-03-31 $1,420,400 134,000
2024-12-31 $3,351,868 189,800
2024-12-31 $212,025 12,006
2024-12-31 $5,605,284 317,400
2024-09-30 $574,147 116,460
2024-09-30 $141,491 28,700
2024-09-30 $300,237 60,900
2024-06-30 $3,624,355 809,008
2024-06-30 $190,848 42,600
2024-06-30 $292,096 65,200
2024-03-31 $208,520 40,100
2024-03-31 $2,862,947 550,567
2024-03-31 $273,000 52,500
2023-12-31 $1,157,967 171,044
2023-12-31 $469,161 69,300
2023-12-31 $394,014 58,200
2023-09-30 $471,042 70,200
2023-09-30 $3,636,228 541,912
2023-09-30 $598,532 89,200
2023-06-30 $2,310,336 201,600
2023-06-30 $7,519,341 656,138
2023-06-30 $619,986 54,100
2023-03-31 $1,230,554 61,100
2023-03-31 $1,693,774 84,100
2023-03-31 $6,895,230 342,365
2022-12-31 $1,085,893 47,900
2022-12-31 $3,488,913 153,900
2022-12-31 $4,625,744 204,047
2022-09-30 $1,093,708 58,300
2022-09-30 $3,806,084 202,883
2022-09-30 $2,808,372 149,700
2022-06-30 $4,454,418 238,971
2022-06-30 $3,276,912 175,800
2022-06-30 $1,478,152 79,300
2022-03-31 $3,438,721 190,300
2022-03-31 $1,606,423 88,900

Report a Problem

Category
Description
Email (optional, for follow-up)